Find uplifting stories about heroes, innovations, and solutions
11 results for "lenacapavir"
Nigeria will receive a groundbreaking HIV prevention injection that works for six months with just two doses per year, making protection more accessible than ever. The new drug arrives in March 2026 as part of the country's ambitious plan to end the HIV epidemic.
Scientists discovered that when HIV develops resistance to the groundbreaking drug lenacapavir, the virus loses its ability to spread effectively. This finding offers hope that the twice-yearly injection can remain a powerful tool in preventing and treating HIV.
Kenya becomes the first country to roll out Lenacapavir, a groundbreaking injection that prevents HIV for six months with a single shot. The breakthrough could dramatically reduce the country's 20,000 annual new infections by eliminating daily pill routines.
Kenya just became one of the first countries to offer a groundbreaking HIV prevention drug that requires just two injections per year, completely free to those who need it most. The move brings new hope to 1.4 million Kenyans living with HIV and vulnerable young people facing the highest risk of infection.
Kenya just became one of the first countries to offer a groundbreaking HIV prevention injection that protects people for six months with a single shot. The treatment is completely free and could change the lives of 1.4 million Kenyans living with HIV.
Kenya began administering a groundbreaking HIV prevention injection that's taken just twice a year and reduces transmission risk by more than 99.9 percent. The drug is free for recipients, offering new hope to 1.3 million Kenyans living with HIV.
A revolutionary HIV prevention shot that only requires two doses per year is coming to 271,000 people in Zimbabwe, backed by US support that could prevent more than 9,000 new infections. The groundbreaking injection removes daily pill barriers and offers a new path toward an AIDS-free generation.
Kenya just received its first shipment of Lenacapavir, a groundbreaking HIV prevention treatment that requires just two injections per year instead of daily pills. The new option could dramatically reduce infections among pregnant and breastfeeding women, who face the highest risk.
%2Ffile%2Fattachments%2Forphans%2FFEATUREIMAGE1_176820.jpg)
Starting April 1st, nearly half a million South Africans can access a groundbreaking HIV prevention injection that requires just two doses per year and has shown 100% effectiveness in trials. The free rollout could help end AIDS as a public health threat by 2043.
A twice-yearly injection prevented every single HIV infection in a major clinical trial, offering new hope for Nigeria's 1.9 million people living with HIV. The challenge now is making this breakthrough affordable and accessible to those who need it most.
Scientists discovered that when HIV develops resistance to the breakthrough drug lenacapavir, the virus becomes significantly weaker and struggles to survive. This finding shows the medication is working even better than expected.